Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The ...

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Cencora (COR) to $251 from $237 and keeps an Equal Weight rating on the ...

Buying $100 In COR: If an investor had bought $100 of COR stock 10 years ago, it would be worth $510.85 today based on a price of $256.50 for COR at the time of writing.

Analysts have recently evaluated Cencora and provided 12-month price targets. The average target is $281.67, accompanied by a ...

Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co.

Harrow's "Harrow Cares" program, in partnership with Cencora, aims to improve access and affordability of eye care treatments ...

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. CONSHOHOCKEN ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

CONSHOHOCKEN, Pa., January 08, 2025--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to ...

Cencora (NYSE:COR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings ...